Marco van Vulpen
Since January 2018 Marco van Vulpen has been professor of Radiation Medicine at Delft University of Technology. He is also medical director of the Holland Proton Therapy Center (HollandPTC) in Delft. From Medical Delta he was appointed professor at the Erasmus Medical Center (Erasmus MC) and professor of Radiotherapy at the Leiden University Medical Center (LUMC). He is also a professor and member of the medical staff at the University of Texas at the MD Anderson Cancer Center in Houston.
Prof.dr. Van Vulpen studied medicine at the University of Amsterdam (VUmc) and his protomotion research at the University of Utrecht (2003). The title of his thesis was 'Hyperthermia for prostate cancer'. Van Vulpen then specialized in radiotherapy at the University of Utrecht, where he was appointed as a professor in 2011 and his inaugural lecture was 'The end of radiotherapy'.
From 2013 he was department head of the radiotherapy department at UMC Utrecht, where a 1.5 Tesla MRI linear accelerator was developed. He was chairman of the international consortium, ATLANTIC, for the global introduction of the MRI accelerator.
He is currently appointed as a professor of radiotherapy and a member of the medical staff at the MD Anderson Cancer Center in Houston, Texas. In 2016 he was appointed as medical director of Holland Proton Therapy Center in Delft and was appointed professor at the Leiden UMC, Erasmus MC and TU Delft.
His research focuses on the development and clinical introduction of new radiotherapy techniques, such as the MRI accelerator and proton therapy, especially in the context of determining the clinical value.